Bessemer Group Inc. raised its stake in shares of Hamilton Lane Inc. (NASDAQ:HLNE - Free Report) by 6.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 173,490 shares of the company's stock after acquiring an additional 11,103 shares during the period. Bessemer Group Inc. owned approximately 0.31% of Hamilton Lane worth $25,793,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Hamilton Lane by 28.4% during the fourth quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company's stock worth $577,681,000 after purchasing an additional 863,326 shares during the last quarter. Invesco Ltd. raised its stake in shares of Hamilton Lane by 25.3% during the fourth quarter. Invesco Ltd. now owns 1,923,253 shares of the company's stock worth $284,738,000 after purchasing an additional 388,019 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Hamilton Lane by 229.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company's stock worth $191,321,000 after purchasing an additional 900,283 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Hamilton Lane by 4.1% during the fourth quarter. Geode Capital Management LLC now owns 1,149,928 shares of the company's stock worth $170,280,000 after purchasing an additional 44,865 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its stake in shares of Hamilton Lane by 10.0% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 780,363 shares of the company's stock worth $115,533,000 after purchasing an additional 70,976 shares during the last quarter. 97.40% of the stock is owned by institutional investors and hedge funds.
Hamilton Lane Price Performance
HLNE stock traded down $0.10 on Friday, reaching $144.14. 6,419,561 shares of the company's stock were exchanged, compared to its average volume of 507,522. The stock has a fifty day moving average of $153.70 and a 200-day moving average of $151.55. Hamilton Lane Inc. has a twelve month low of $120.86 and a twelve month high of $203.72. The firm has a market cap of $7.72 billion, a PE ratio of 26.74 and a beta of 1.25. The company has a quick ratio of 4.83, a current ratio of 4.83 and a debt-to-equity ratio of 0.31.
Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The company reported $1.21 earnings per share for the quarter, topping analysts' consensus estimates of $1.20 by $0.01. Hamilton Lane had a return on equity of 32.94% and a net margin of 30.50%. The firm had revenue of $197.97 million for the quarter, compared to analyst estimates of $165.49 million. During the same quarter in the prior year, the company posted $1.38 earnings per share. Hamilton Lane's quarterly revenue was up 12.1% on a year-over-year basis. As a group, equities analysts predict that Hamilton Lane Inc. will post 4.97 EPS for the current fiscal year.
Hamilton Lane Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, July 7th. Shareholders of record on Friday, June 20th will be issued a $0.54 dividend. This is a positive change from Hamilton Lane's previous quarterly dividend of $0.49. The ex-dividend date is Friday, June 20th. This represents a $2.16 annualized dividend and a yield of 1.50%. Hamilton Lane's dividend payout ratio is 40.07%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the company. JPMorgan Chase & Co. cut their price target on Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Oppenheimer lowered Hamilton Lane from an "outperform" rating to a "market perform" rating in a report on Thursday, May 15th. Wall Street Zen lowered Hamilton Lane from a "hold" rating to a "sell" rating in a report on Friday, June 6th. Keefe, Bruyette & Woods lowered their price objective on Hamilton Lane from $162.00 to $155.00 and set a "market perform" rating on the stock in a report on Monday, June 2nd. Finally, Morgan Stanley lowered their price objective on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating on the stock in a report on Monday, April 14th. Two equities research analysts have rated the stock with a sell rating and six have given a hold rating to the company. According to data from MarketBeat, Hamilton Lane presently has an average rating of "Hold" and an average target price of $164.29.
Get Our Latest Report on Hamilton Lane
About Hamilton Lane
(
Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
See Also

Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.